Semin Radiat Oncol 2015 Oct
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.
Related Questions
As it is suggested for larger tumors treated with surgery, based on post hoc CALGB analysis?
New answer by Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System (January 22, 2016)
From the multiple phase III trials of postop adjuvant therapy for NSCLC, one could reasonably extrapolate that a policy to give chemo to all stage IB pts after SAbR does not m...
The NCCN guidelines call for pathological mediastinal lymph node staging for all NSCLC except in solid tumors <1cm and non-solid lesions < ...
New answer by Radiation Oncologist at University of Wisconsin Hospital & Clinics (July 20, 2016)
Here are some published guidelines for when to perform invasive mediastinal staging:http://www.ncbi.nlm.nih.gov/pubmed/17873169http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224...